IperionX Limited Sponsored ADR (NASDAQ:IPX – Get Free Report) Chairman Todd Hannigan bought 300,000 shares of the firm’s stock in a transaction on Monday, July 13th. The shares were purchased at an average cost of $3.59 per share, with a total value of $1,077,000.00. Following the transaction, the chairman directly owned 26,633,334 shares in the company, valued at approximately $95,613,669.06. This trade represents a 1.14% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Todd Hannigan also recently made the following trade(s):
- On Friday, July 10th, Todd Hannigan bought 225,000 shares of IperionX stock. The shares were purchased at an average cost of $3.58 per share, with a total value of $805,500.00.
- On Tuesday, April 28th, Todd Hannigan acquired 220,000 shares of IperionX stock. The stock was acquired at an average cost of $4.48 per share, with a total value of $985,600.00.
- On Wednesday, April 29th, Todd Hannigan purchased 260,000 shares of IperionX stock. The stock was acquired at an average cost of $4.20 per share, for a total transaction of $1,092,000.00.
IperionX Stock Performance
IperionX stock opened at $25.03 on Monday. The company has a current ratio of 4.03, a quick ratio of 4.00 and a debt-to-equity ratio of 0.03. The firm’s fifty day moving average is $34.28 and its 200 day moving average is $37.50. IperionX Limited Sponsored ADR has a 12-month low of $21.66 and a 12-month high of $61.45.
Hedge Funds Weigh In On IperionX
Wall Street Analyst Weigh In
Several brokerages recently issued reports on IPX. BTIG Research upped their price target on IperionX from $40.00 to $55.00 and gave the stock a “buy” rating in a report on Friday, June 5th. Weiss Ratings restated a “sell (e+)” rating on shares of IperionX in a research note on Tuesday, April 21st. Alliance Global Partners reaffirmed a “buy” rating on shares of IperionX in a report on Tuesday, April 28th. Finally, Roth Capital reiterated a “buy” rating on shares of IperionX in a research note on Monday, June 8th. Five analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $60.33.
Check Out Our Latest Research Report on IPX
About IperionX
IperionX (NASDAQ: IPX) is a mineral technology company focused on the production and commercialization of highâpurity titanium and zirconium products. The company’s core activities include the development of advanced mineral sands projects and the deployment of proprietary processing technologies aimed at supplying feedstocks to aerospace, defense, additive manufacturing and battery markets.
At the heart of IperionX’s operations is the Stony Creek Project in Virginia, where the company holds significant mineral sands rights.
Further Reading
- Five stocks we like better than IperionX
- 3 Overlooked Stocks Positioned for the Next Market Rotation
- 3 Non-Tech Stocks Still Winning Big on AI
- Achieve Robust Diversification With These 3 Equal-Weight ETFs
- 3 Rare-Earth ETFs That Help Investors Balance Exposure and Risk
Receive News & Ratings for IperionX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IperionX and related companies with MarketBeat.com's FREE daily email newsletter.
